Clinical Trial Update: Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating horse T-cell leukemia/lymphoma ATG and cyclosporine in patients with aplastic anemia unresponsive to or suboptimally responsive to rabb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Hypoplastic Anemia

Drugs mentioned

• hor se ATG (anti-thymocyte globulin (horse-derived) with cyclosporine)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Anemia, Aplastic, Anemia, Hypoplastic | Phase 2 | Status: COMPLETED | Results posted: 2017-02-23